XERS

XERS Total Non-Current Liabilities

$232.07MQuarterly · USD

Period ending:

XERS FY Total Non-Current LiabilitiesUSD
XERS FY Total Non-Current Liabilities2016-12-31: $62.94M2017-12-31: $97.97M2018-12-31: $34.45M2019-12-31: $67.21M2020-12-31: $97.18M2021-12-31: $130.09M2022-12-31: $225.71M2023-12-31: $234.19M2024-12-31: $252.23M2025-12-31: $260.26M$260.26M$0.00
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

XERS total non-current liabilities history

Long-term obligations due beyond one year. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Xeris Biopharma Holdings Inc Total Non-Current Liabilities — Annual fiscal periods (USD)
Period endingTotal Non-Current Liabilities (USD)
260,264,000
252,232,000
234,191,000
225,714,000
130,090,000
97,183,000
67,213,000
34,450,000
97,968,000
62,940,000

Compare total non-current liabilities

All XERS financial metrics · XERS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.